Physician profile
James E Baker
NPI 1356365324
$1,202.05
in general payments reported to CMS, 2019-2025
17 companies · $92.51 in 2025
The $92.51 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $100 · 2021: $127 · 2022: $20.11 · 2023: $36.82 · 2024: $67.00 · 2025: $92.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $231.85 | 2019-2020 | |
| Exact Sciences Corporation | $175.00 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $169.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $139.19 | 2019 | |
| Astellas Pharma US INC | $127.32 | 2021 | |
| Novo Nordisk INC | $83.36 | 2019 | |
| Glaxosmithkline, LLC. | $46.08 | 2019-2022 | |
| Pfizer INC. | $44.21 | 2019-2024 | |
| Amgen INC. | $30.95 | 2019 | |
| Shire North American Group INC | $30.63 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.48 | 2019 | |
| Amarin Pharma, INC. | $17.76 | 2019 | |
| Ethicon US, LLC | $16.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.22 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.95 | 2019 | |
| Lilly USA, LLC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.